Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.41 Analyst target: $4.58 Upside: 225.04%
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
See the full interactive analysis & chart →Informational only — not investment advice.